Et al Phillip Frost MD - 02 Dec 2024 Form 4/A - Amendment Insider Report for Fluent, Inc. (FLNT)

Role
10%+ Owner
Signature
/s/ Phillip Frost, M.D., Individually
Issuer symbol
FLNT
Transactions as of
02 Dec 2024
Net transactions value
+$1,499,676
Form type
4/A - Amendment
Filing time
06 Dec 2024, 12:10:46 UTC
Date Of Original Report
04 Dec 2024
Previous filing
29 Nov 2024
Next filing
11 Dec 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FLNT Pre-Funded Warrant Award $1,499,676 +647,892 $2.31 647,892 02 Dec 2024 Common Stock 647,892 $0.000500 Held by Frost Gamma Investments Trust F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 4, 2024, the reporting person filed a Form 4 which inadvertently reported the transaction code as "P." The transaction code should have been reported as "A" for a grant, award or other acquisition pursuant to Rule 16b-3(d).
F2 The Pre-Funded Warrants will terminate when exercised in full.
F3 These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.